...
机译:术后深静脉血栓形成,肺栓塞和心肌梗死在患者中脊柱创伤后的治疗抗凝后
Univ Maryland Dept Orthopaed 110 South Paca St 6th Floor Suite 300 Baltimore MD 21201 USA;
Univ Maryland Dept Neurosurg Baltimore MD 21201 USA;
Univ Maryland Dept Orthopaed 110 South Paca St 6th Floor Suite 300 Baltimore MD 21201 USA;
Univ Maryland Dept Orthopaed 110 South Paca St 6th Floor Suite 300 Baltimore MD 21201 USA;
Univ Maryland Dept Orthopaed 110 South Paca St 6th Floor Suite 300 Baltimore MD 21201 USA;
Univ Maryland Dept Neurosurg Baltimore MD 21201 USA;
Univ Maryland Dept Orthopaed 110 South Paca St 6th Floor Suite 300 Baltimore MD 21201 USA;
Univ Maryland Dept Orthopaed 110 South Paca St 6th Floor Suite 300 Baltimore MD 21201 USA;
Univ Maryland Dept Orthopaed 110 South Paca St 6th Floor Suite 300 Baltimore MD 21201 USA;
Univ Maryland Dept Orthopaed 110 South Paca St 6th Floor Suite 300 Baltimore MD 21201 USA;
Univ Maryland Dept Orthopaed 110 South Paca St 6th Floor Suite 300 Baltimore MD 21201 USA;
heparin infusion; low-molecular-weight heparin; spine surgery complications; therapeutic anticoagulation; thromboembolic events; warfarin;
机译:术后深静脉血栓形成,肺栓塞和心肌梗死在患者中脊柱创伤后的治疗抗凝后
机译:在美国总髋关节置换术后的抗凝模式:深静脉血栓形成,肺栓塞和Rivaroxaban和Warfarin的并发症频率
机译:抗凝治疗对患者患者肺栓塞风险的影响,患者远端深静脉血栓形成
机译:口服活性肝素衍生物预防深静脉血栓形成和肺栓塞
机译:新药开发的研究管理:开发DHE和肝素固定组合以预防术后深静脉血栓形成和肺栓塞的可行性研究。
机译:深静脉血栓形成或肺栓塞或两者兼有的患者抗凝治疗三个月至六个月:随机试验
机译:抗凝治疗对患者患者肺栓塞风险的影响 - 患者患者分离远端深静脉血栓形成